GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $265,000 | -4.0% | 6,091 | -3.8% | 0.06% | +12.0% |
| Q1 2022 | $276,000 | +6.6% | 6,332 | +7.7% | 0.05% | +8.7% |
| Q4 2021 | $259,000 | +23.3% | 5,880 | +7.2% | 0.05% | +12.2% |
| Q3 2021 | $210,000 | -3.7% | 5,483 | +0.2% | 0.04% | -6.8% |
| Q2 2021 | $218,000 | +5.8% | 5,471 | -5.0% | 0.04% | -6.4% |
| Q1 2021 | $206,000 | 0.0% | 5,761 | -1.3% | 0.05% | 0.0% |
| Q4 2020 | $206,000 | -4.2% | 5,838 | +0.2% | 0.05% | -20.3% |
| Q3 2020 | $215,000 | -10.4% | 5,824 | +0.2% | 0.06% | -21.3% |
| Q2 2020 | $240,000 | -1.2% | 5,811 | +0.1% | 0.08% | -20.2% |
| Q1 2020 | $243,000 | -15.0% | 5,805 | -2.8% | 0.09% | -2.1% |
| Q4 2019 | $286,000 | +6.3% | 5,975 | +0.2% | 0.10% | -5.9% |
| Q3 2019 | $269,000 | +10.2% | 5,963 | -0.5% | 0.10% | +2.0% |
| Q2 2019 | $244,000 | +8.4% | 5,995 | +11.6% | 0.10% | +1.0% |
| Q1 2019 | $225,000 | +9.8% | 5,373 | +0.2% | 0.10% | -12.4% |
| Q4 2018 | $205,000 | – | 5,361 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |